IOVA : Iovance Biotherapeutics stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 3 Wall Street analysts offering Iovance Biotherapeutics stock forecast in the last 6 months have average price target of $43.33 with a high forecast of $50.0 and a low forecast of $35.0. The average Iovance Biotherapeutics stock forecast represents a 43.52% increase from the last price of $30.19. From AI system, total return is 1826.17% from 1567 forecasts. For Iovance Biotherapeutics stock forecast 2021, 8 predictions are offered for each month of 2021 with average Iovance Biotherapeutics stock forecast of $51.03, a high forecast of $68.71, and a low forecast of $31.89. The average Iovance Biotherapeutics stock forecast 2021 represents a 69.03% increase from the last price of $30.19. For Iovance Biotherapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average Iovance Biotherapeutics stock forecast of $54.54, a high forecast of $67.62, and a low forecast of $45.89. The average Iovance Biotherapeutics stock forecast 2022 represents a 80.66% increase from the last price of $30.19. For Iovance Biotherapeutics stock forecast 2025, 12 predictions are offered for each month of 2025 with average Iovance Biotherapeutics stock forecast of $65.61, a high forecast of $71.34, and a low forecast of $56.6. The average Iovance Biotherapeutics stock forecast 2025 represents a 117.34% increase from the last price of $30.19. For Iovance Biotherapeutics stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Iovance Biotherapeutics stock forecast of $66.31, a high forecast of $69.61, and a low forecast of $64.99. The average Iovance Biotherapeutics stock forecast 2026 represents a 119.64% increase from the last price of $30.19. For Iovance Biotherapeutics stock forecast 2030, 12 predictions are offered for each month of 2030 with average Iovance Biotherapeutics stock forecast of $86.56, a high forecast of $97.16, and a low forecast of $79.04. The average Iovance Biotherapeutics stock forecast 2030 represents a 186.72% increase from the last price of $30.19. For Iovance Biotherapeutics stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Iovance Biotherapeutics stock forecast of $93.15, a high forecast of $96.58, and a low forecast of $88.99. The average Iovance Biotherapeutics stock forecast 2031 represents a 208.53% increase from the last price of $30.19. Please, see more forecasts below.